Product image of QARZIBA 4.5mg X 20ml (Dinutuximab beta) 4.5mg/ml x 20mg Vials supplied by GNH India

QARZIBA 4.5mg X 20ml

Active Ingredient:
Dinutuximab beta
Form:
Vials
Brand:
QARZIBA 4.5mg
Origin:
CHINA

QARZIBA 4.5mg X 20ml (Dinutuximab beta Vials) 4.5mg/ml x 20mg

QARZIBA 4.5mg X 20ml contains dinutuximab beta, a monoclonal antibody used in cancer therapy. This vial form (4.5mg/ml x 20mg) is stored refrigerated (2-8°C) and requires careful handling. Dinutuximab beta is prescribed under medical supervision for specific oncology indications.

Strength

4.5mg/ml x 20mg

Pack Size

1s

Storage

2-8°

Manufacturer / TM Owner

Patheon Italia S.P.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Dinutuximab beta, the active ingredient in QARZIBA 4.5mg X 20ml, is used in the treatment of certain cancers, particularly neuroblastoma in pediatric patients. It belongs to a class of drugs called monoclonal antibodies, which target cancer cells. This medication is typically administered as part of a broader cancer treatment regimen under close medical supervision.

Side Effects

  • Dinutuximab beta works by helping the body's immune system recognize and attack cancer cells. Patients may experience immune-related effects as the body responds to treatment. Common effects include infusion reactions, which can range from mild to severe, and require monitoring during administration.

Precautions & Warnings

  • QARZIBA 4.5mg X 20ml must be handled with care due to its biological nature. It should be stored refrigerated (2-8°C) and protected from light. Administration requires trained healthcare professionals to manage potential infusion reactions. Patients should report any unusual symptoms immediately during treatment.

Avoid Interactions

  • Dinutuximab beta may interact with other medications that suppress the immune system, such as corticosteroids or chemotherapy. Live vaccines should be avoided during treatment due to the risk of infection. Patients should inform their healthcare provider about all medications and supplements they are taking before starting this therapy.

Frequently Asked Questions

Dinutuximab beta is used to treat certain cancers, including high-risk neuroblastoma in pediatric patients.

This medication is administered intravenously by healthcare professionals in a clinical setting.

Common effects include infusion reactions, pain, fever, and low blood pressure during administration.

No, QARZIBA 4.5mg X 20ml must be stored refrigerated between 2-8°C.

This medication is prescribed under medical supervision and may not be suitable for everyone. Consult your healthcare provider for personalized advice.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Dinutuximab beta

QARZIBA 4.5mg

QARZIBA 4.5mg

4.5mg/ml x 20mg Vials
Qarziba

Qarziba

4.5mg/ml Vials

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT